Work

Effects of dose modification of eribulin mesylate in patients with locally recurrent or metastatic breast cancer.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.26_suppl.157

Authors: Claudio Faria, Xuan Li, Annette Powers, Linda T. Vahdat

Institutions: Eisai (United States), Weill Cornell Medicine

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591484160

Cites:

Cited by: 2

Related to: 10